Oncology trials ..8 Dec 2022 18:30
There have been trials that have taken around two years !! The key is gaining Breakthrough Designation in my opinion ..
“ Two of the fastest development programs identified are Gilead’s Harvoni and AstraZeneca’s Tagrisso (NSCLC). “In the case of Harvoni and Tagrisso, both had Breakthrough Therapy designations, so both were deemed by the FDA as being transformative and capable of changing the standard of care,” noted Munos. Both drugs had multiple expedited designations, as did the 10 fastest oncology programs, the top five of which had clinical durations of 25 months or less. Both Gilead and AstraZeneca obtained FDA approval with relatively small clinical programs. “Gilead was able to clinch the registration with a smaller program than would have been required if the compound had not been that good,” noted Munos. “I don’t think anyone wanted to keep it from reaching the market as soon as possible.””
Just for factual information of course.
Take care all ..